ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

15 Health Benefits of Chia Seeds, According to Science

Tangerine Oil: A Citrusy Essential Oil With Well-Rounded Uses

Natural Remedies for the Prevention of Dry Eyes

Magnesium Deficiency Raises Your Risk of Many Chronic Ailments

Resveratrol supplementation improves arterial stiffness in type 2 diabetics

CoQ10's Potential Capabilities for Your Health

How Can Melatonin Benefit You?

Cloves: Boost Your Immune System the Sweet and Spicy Way

8 Chia Seed Recipes

Cinnamon Health Benefits Proven

 
Print Page
Email Article

New Study Indicates Benefits Of Ampligen in Treatment of Severe Chronic Fatigue Syndrome (CFS)

  [ 52 votes ]   [ Discuss This Article ]
By Source: PRNewswire • www.ProHealth.com • September 13, 1999


(BRUSSELS, Belgium)Sept. 13-- Hemispherx Biopharma, Inc. today announced results of an independent evaluation of the potential pharmaco-economic benefits of Ampligen® in treatment of severe Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME), including a decrease in the number of doses of other medicines used with Ampligen® and inpatient hospital treatment days.

The findings were presented at the Second World Conference on CFS in Brussels and developed by EPI-Q, an independent company that conducts pharmaco-economic studies under grant support.

The results of this analysis indicated a significant decrease in the number of doses of concomitant medications required between the treatment and control groups. The patients receiving Ampligen®, Hemispherx's lead compound, also demonstrated the need for substantially fewer inpatient hospital treatment days -- 101 days for the placebo group versus 15 days for the Ampligen® group -- during the 24-week study period. This translated into an annualized decrease in hospital charges of $5,806.78 for hospitalizations alone. With the addition of concomitant medication cost, the mean annualized health-care charges for the treatment group were $2,097.52 versus $8,606.14 in the placebo group.

The object of this study was to document the potential pharmaco-economic impact of Ampligen® in the treatment of CFS/ME, which frequently leads to persistent disability and requires frequent intervention in the health-care setting as well as long-term outpatient treatment of pain and central nervous system symptoms. This increased utilization of health-care services leads to significant financial burden to patients and payers. In fact, independent reports estimate those costs to U.S. insurance companies in excess of several billion dollars per year.

As part of the analysis, pharmaco-economic data, including medication use, cost and charges of hospitalizations and emergency-room visits, were collected retrospectively during a randomized, multi-center, double-blind, placebo- controlled trial of 92 patients meeting the CFS/ME United States Centers for Disease Control and Prevention definition. Subjects were randomized to receive 24 weeks of Ampligen® versus placebo administered by intravenous infusion twice weekly.

Independent data from Dr. Kenny De Meirleir et al also presented at the Second World Conference on CFS indicate that the duration of Ampligen® positive response remains constant for at least 42 months following treatment initiation. Therefore, the 3.5-year annualized costs of Ampligen® and placebo groups are projected to be $13,854.70 and $30,121.58, respectively. Thus, twice-weekly infusion of Ampligen® as a treatment of CFS/ME can reduce the utilization of health-care services and concomitant medications resulting overall in more than 100% return on investment for insurance carriers.

Information contained in this news release other than historical information, should be considered forward-looking and is subject to various risk factors and uncertainties. For instance, the strategies and operations of Hemispherx involve risks of competition, changing market conditions, changes in laws and regulations affecting these industries and numerous other factors discussed in this release and in the Company's filings with the Securities and Exchange Commission. Accordingly, actual results may differ materially from those in any forward-looking statements.

This article also appeared in the CFIDS & FM Health Resource Email Bulletin on September 16, 1999.

Source: PRNewswire



Post a Comment

Featured Products From the ProHealth Store
Ultra EPA  - Fish Oil Vitamin D3 Extreme™ Ultra ATP+, Double Strength


Article Comments



Be the first to comment on this article!

Post a Comment


 
Optimized Curcumin Longvida with Omega-3

Featured Products

Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid

Natural Remedies

Nutrients to Combat the Modern Stress Epidemic Nutrients to Combat the Modern Stress Epidemic
Breaking Through the Mental Fog Breaking Through the Mental Fog
How One Tiny Molecule Turned into One Huge Health Breakthrough How One Tiny Molecule Turned into One Huge Health Breakthrough
SAD? Coping with Seasonal Affective Disorder SAD? Coping with Seasonal Affective Disorder
Thyroid Health and Fibromyalgia Thyroid Health and Fibromyalgia

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map